Geno-Clinical Model to Aid in the Diagnosis of Myelodysplastic Syndrome (MDS) Versus Chronic Myelomonocytic Leukemia (CMML)

Hilton C. Beau; Sekeres Mikkael A.; Meggendorfer Manja; Walter Wencke; Hutter Stephan; Padron Eric; Savona Michael R.; Gerds Aaron T.; Guan Yihong; Sallman David A.; Mukherjee Sudipto; Patnaik Mrinal M.; Smith Brianna; Nagata Yasunobu; Adema Vera; Hasipek Metis; Hirsch Cassandra M.; Przychodzen Bartlomiej P.; Komrokji Rami S.; Jha Babal K.; Haferlach Claudia; Maciejewski Jaroslaw P.; Haferlach Torsten; Nazha Aziz

首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Geno-Clinical Model to Aid in the Diagnosis of Myelodysplastic Syndrome (MDS) Versus Chronic Myelomonocytic Leukemia (CMML)

【24h】

Geno-Clinical Model to Aid in the Diagnosis of Myelodysplastic Syndrome (MDS) Versus Chronic Myelomonocytic Leukemia (CMML)

机译：基因临床模型，有助于诊断骨髓增生术综合征（MDS）与慢性骨髓细胞白血病（CMML）

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Blood: The Journal of the American Society of Hematology 》 |2018年第novaelatreatmentappr期| 共5页
作者
Hilton C. Beau; Sekeres Mikkael A.; Meggendorfer Manja; Walter Wencke; Hutter Stephan; Padron Eric; Savona Michael R.; Gerds Aaron T.; Guan Yihong; Sallman David A.; Mukherjee Sudipto; Patnaik Mrinal M.; Smith Brianna; Nagata Yasunobu; Adema Vera; Hasipek Metis; Hirsch Cassandra M.; Przychodzen Bartlomiej P.; Komrokji Rami S.; Jha Babal K.; Haferlach Claudia; Maciejewski Jaroslaw P.; Haferlach Torsten; Nazha Aziz;
展开▼
作者单位

Case Western Reserve Univ Cleveland Clin Lerner Coll Med Cleveland OH 44106 USA;

Cleveland Clin Taussig Canc Inst Dept Hematol &

Med Oncol Leukemia Program Cleveland OH 44106;

MLL Munich Leukemia Lab Munich Germany;

MLL Munich Leukemia Lab Munich Germany;

MLL Munich Leukemia Lab Munich Germany;

H Lee Moffitt Canc Ctr &

Res Inst Tampa FL USA;

Vanderbilt Univ Med Ctr Dept Med Div Hematol Oncol Nashville TN USA;

Cleveland Clin Taussig Canc Inst Cleveland OH 44106 USA;

Cleveland Clin Fdn Taussig Canc Inst Dept Translat Hematol &

Oncol Res 9500 Euclid Ave;

H Lee Moffitt Canc Ctr &

Res Inst Dept Malignant Hematol Tampa FL USA;

Cleveland Clin Taussig Canc Inst Dept Hematol &

Med Oncol Leukemia Program Cleveland OH 44106;

Mayo Clin Div Hematol Rochester MN USA;

Vanderbilt Univ Med Ctr Nashville TN USA;

Cleveland Clin Fdn Taussig Canc Inst Dept Translat Hematol &

Oncol Res 9500 Euclid Ave;

Cleveland Clin Taussig Canc Inst Dept Translat Hematol &

Oncol Res Cleveland OH 44106 USA;

Cleveland Clin Fdn Taussig Canc Inst Dept Translat Hematol &

Oncol Res 9500 Euclid Ave;

Cleveland Clin Fdn Taussig Canc Inst Dept Translat Hematol &

Oncol Res 9500 Euclid Ave;

Cleveland Clin Taussig Canc Inst Dept Translat Hematol &

Oncol Res Cleveland OH 44106 USA;

H Lee Moffitt Canc Ctr &

Res Inst Dept Malignant Hematol Tampa FL USA;

Cleveland Clin Taussig Canc Inst Dept Translat Hematol &

Oncol Res Cleveland OH 44106 USA;

MLL Munich Leukemia Lab Munich Germany;

Cleveland Clin Fdn Taussig Canc Inst Dept Translat Hematol &

Oncol Res 9500 Euclid Ave;

MLL Munich Leukemia Lab Munich Germany;

Cleveland Clin Taussig Canc Inst Dept Hematol &

Med Oncol Leukemia Program Cleveland OH 44106;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类血液及淋巴系疾病 ;
关键词

相似文献

外文文献
中文文献
专利

1. Geno-Clinical Model to Aid in the Diagnosis of Myelodysplastic Syndrome (MDS) Versus Chronic Myelomonocytic Leukemia (CMML) [J] . Hilton C. Beau, Sekeres Mikkael A., Meggendorfer Manja, Blood: The Journal of the American Society of Hematology . 2018 ,第NovaelaTreatmentAppr期

机译：基因临床模型，有助于诊断骨髓增生术综合征（MDS）与慢性骨髓细胞白血病（CMML）
2. Initial Results of a Phase 2 Study of Guadecitabine (SGI-110), a Novel Subcutaneous (sc) Hypomethylating Agent, for Patients with Previously Untreated Intermediate-2 or High Risk Myelodysplastic Syndromes (MDS) or Chronic Myelomonocytic Leukemia (CMML) [J] . Montalban-Bravo Guillermo, Bose Prithviraj, Alvarado Yesid, Blood: The Journal of the American Society of Hematology . 2016 ,第22期

机译：瓜地西他滨（SGI-110）（一种新型皮下（sc）次甲基化剂）用于先前未治疗的中度2或高危骨髓增生异常综合征（MDS）或慢性粒细胞性白血病（CMML）的患者的2期研究的初步结果
3. Initial Results of a Phase 2 Study of Guadecitabine (SGI-110), a Novel Subcutaneous (sc) Hypomethylating Agent, for Patients with Previously Untreated Intermediate-2 or High Risk Myelodysplastic Syndromes (MDS) or Chronic Myelomonocytic Leukemia (CMML) [J] . Montalban-Bravo Guillermo, Bose Prithviraj, Alvarado Yesid, Blood: The Journal of the American Society of Hematology . 2016 ,第22期

机译：瓜地西他滨（SGI-110）（一种新型皮下（sc）次甲基化剂）用于先前未治疗的中度2或高危骨髓增生异常综合征（MDS）或慢性粒细胞性白血病（CMML）的患者的2期研究的初步结果
4. Ras gene mutation in acute myeloid leukemia and Myelodysplastic syndromes: a meta-analysis of its occurrence and prognostic relevance [C] . Cheng Jingru, Wang Peng, Zhang Tai, International Conference on Advanced Materials and Computer Science . 2016

机译：RAS基因突变在急性髓性白血病和髓细胞增强综合征中：荟萃分析其发生和预后相关性
5. CD16xCD33 bispecific killer cell engager (BiKE) activates natural killer (NK) cells from myelodysplastic syndrome (MDS) patients against primary MDS and myeloidderived suppressor cell (MDSC) CD33-positive targets. [D] . Gleason, Michelle K. 2014

机译：CD16xCD33双特异性杀伤细胞接合剂（BiKE）激活来自骨髓增生异常综合征（MDS）患者的自然杀伤（NK）细胞，以抵抗原发性MDS和髓样抑制细胞（MDSC）CD33阳性靶标。
6. Characteristics and outcomes of patients with multiple myeloma (MM) who develop therapy (t)-related myelodysplastic syndrome (MDS) t-chronic myelomonocytic leukemia (CMML) or t-acute myeloid leukemia (AML) [O] . Naveen Pemmaraju, Dhaval Shah, Hagop Kantarjian, -1

机译：患有治疗性（t）相关性骨髓增生异常综合症（MDS）t型慢性粒细胞性白血病（CMML）或t型急性髓性白血病（AML）的多发性骨髓瘤（MM）患者的特征和结局
7. Pre-Transplant Azacitidine and Allogeneic Hematopoietic Cell Transplant (HCT) Outcomes of One Hundred Fifty-Nine Patients up to Age Seventy-Five with Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML) [O] . Field Teresa, Perkins Janelle, Hillgruber Ryan, 2014

机译：一百五十九名直至75岁的骨髓增生异常综合症（MDS）或慢性粒细胞性白血病（CMML）患者的移植前阿扎胞苷和同种异体造血细胞移植（HCT）结果
8. Submittal for myelodysplastic syndromes (MDS) among people reporting exposure to toluene/xylene and other independent risk factors. [R] . 2015

机译：在报告接触甲苯/二甲苯和其他独立危险因素的人群中提交myelodysplastic综合征（mDs）。

Geno-Clinical Model to Aid in the Diagnosis of Myelodysplastic Syndrome (MDS) Versus Chronic Myelomonocytic Leukemia (CMML)

著录项

相似文献

相关主题

期刊订阅